Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy

Kidney International

Volumn 73, Issue 11, 2008, Pages 1316-1319

  Murcutt, G ^a   Edwards, J ^b   Boakye, J ^a   Davenport, A ^a,c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Hemodialysis; Radioiodine (131I); Risk; Safety

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ARTICLE; CHRONIC KIDNEY FAILURE; DRUG CLEARANCE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION HAZARD; RADIOACTIVITY; THYROID CARCINOMA; URINARY EXCRETION;

EID: 43749088503     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.95     Document Type: Article

References (13)

1. E.F. Vonesh J. Moran Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis J Am Soc Nephrol 10 1999 354 365
2. Radioactive substances act 1993 (RSA93) 1993 Her Majestey's Stationary Office London
3. European Best Practice Guidelines for hemodialysis Dialysis fluid quality 17 Suppl 7 2002 45 62
4. The Water Supply (Water Quality) (England and Wales) Regulations 200(Statutory Instrument no. 3184). Prescribed concentrations and values. http://www.dwi.gov.uk/regs/si384/3184.htm#schl .
5. Renal Association Standards Treatment of Adults and Children with Renal Failure Standards and Audit Measures 3rd edn. 2002 Royal College of Physicians London, UK
6. International commission of radiological protection (ICRP) 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60 Ann ICRP 21 1991 1 3
7. 131I therapy for thyroid cancer: cumulative dose from in-patients, discharge planning and personnel requirements Nucl Med Commun 26 2005 623 631
8. 131I therapy of thyroid carcinoma in patients on hemodialysis for chronic renal failure Health Phys 92 Suppl 2 2007 S45 S49
9. F. Courbon O. Caselles S. Zerdoud Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications Q J Nucl Med Mol Imaging 50 2006 363 370
10. 131I kinetics and dosimetry in thyroid cancer patients—a pharmacokinetic model Health Phys 91 2006 227 237
11. J.P. Holst K.D. Burman F. Atkins Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis Thyroid 15 2005 1321 1331
12. C. Alevizaki M. Molfetas A. Samartzis Iodine 131 treatment for differentiated thyroid carcinoma in patients with end stage renal failure: dosimetric, radiation safety, and practical considerations Hormones (Athens) 5 2006 276 287
13. A. Davenport Intradialytic complications during hemodialysis Hemodial Int 10 2006 162 167